MedTrace Logo

Perceptions of Vaping Products

NCT06868368 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2025-12-22

No results posted yet for this study

Summary

This clinical trial studies the effects, appeal, and abuse liability of 6-methyl nicotine (metatine) electronic cigarettes among young adults.

Conditions

  • Abuse Tobacco
  • Exposure

Interventions

OTHER

Biospecimen Collection

Undergo blood sample collection

OTHER

Survey Administration

Complete Surveys

BEHAVIORAL

Vaping Topography

Use e-cigarette connected to a topography device

OTHER

Participant's Own Preferred E-cigarette

Participant vapes their own preferred e-cigarette for 30 minutes

OTHER

Nicotine E-cigarette

Participant vapes a commercially available nicotine e-cigarette for 30 minutes

OTHER

6-methyl-nicotine (metatine) e-cigarette

Participant vapes a commercially available metatine e-cigarette for 30 minutes

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Alayna P Tackett, PhD · Ohio State University Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
34 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-03
Primary Completion
2025-11-04
Completion
2025-11-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06868368 on ClinicalTrials.gov